SearchDictionaryMobileLogin

Effects of ciclosporin and protein synthesis inhibitors on cutaneous inflammation in mouse skin.

AbstractCiclosporin is clinically effective in a variety of inflammatory skin diseases. We have therefore studied the effects of the drug on cutaneous inflammation in mice. Ciclosporin inhibited the inflammatory response to 12-O-tetradecanoylphorbol-13-acetate (TPA) and to the contact sensitising agent oxazolone when applied topically to mouse skin. The drug had no effect on arachidonic acid-induced inflammation. The protein synthesis inhibitor cycloheximide showed a similar profile of activity. Ciclosporin, like actinomycin D but unlike cycloheximide, was only effective in inhibiting the inflammatory response to TPA if given 0.5 h before, but not 2 h, after TPA. These results suggest that the anti-inflammatory activity of ciclosporin in the skin is due to an effect on the production of proinflammatory proteins.
AuthorsR J Griffiths, B E Wood, S Li, A Blackham (Affiliation: Department of Pharmacology, Fisons plc Pharmaceutical Division, Loughborough, Leics., UK.)
JournalSkin pharmacology : the official journal of the Skin Pharmacology Society (Skin Pharmacol) Vol. 2 Issue 1 Pg. 30-7 ( 1989) ISSN: 1011-0283 SWITZERLAND
PMID2560651 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Arachidonic Acids
  • Cyclosporins
  • Protein Synthesis Inhibitors
  • Oxazolone
  • Tetradecanoylphorbol Acetate
  • Dactinomycin
  • Arachidonic Acid
  • Cycloheximide
  • Peroxidase
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal
  • Arachidonic Acid
  • Arachidonic Acids (antagonists & inhibitors)
  • Cycloheximide (pharmacology)
  • Cyclosporins (pharmacology)
  • Dactinomycin (pharmacology)
  • Dermatitis (drug therapy, pathology)
  • Female
  • Hypersensitivity, Delayed (drug therapy)
  • Mice
  • Mice, Inbred Strains
  • Neutrophils (enzymology, metabolism)
  • Oxazolone (antagonists & inhibitors)
  • Peroxidase (metabolism)
  • Protein Synthesis Inhibitors (pharmacology)
  • Skin (pathology)
  • Tetradecanoylphorbol Acetate (pharmacology)